Stacey Folk
Plastic Surgery · Denver, CONPI 1992813034
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.9% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations.
Across 124 payments — averaging $48.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Musculoskeletal Transplant Foundation Inc.$1K
- Sientra, Inc.$814
- Mentor Worldwide LLC$520
- Integra Lifesciences Corporation$419
- Innovation Technologies Inc$301
- plus $1K from 12 others
Across 1 payment — averaging $250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sientra, Inc.$250
What the payments were for
- Travel & lodging$4818%
- Food & beverage$5,49092%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 45 | $1,332 |
| Musculoskeletal Transplant Foundation Inc. | 14 | $1,199 |
| Sientra, Inc. | 10 | $814 |
| Mentor Worldwide LLC | 15 | $520 |
| Integra Lifesciences Corporation | 12 | $419 |
| Innovation Technologies Inc | 3 | $301 |
| Apyx Medical Corporation | 2 | $228 |
| BD | 2 | $192 |
| Merz North America, Inc. | 5 | $186 |
| Davol Inc. | 2 | $179 |
| Motiva USA, LLC | 2 | $175 |
| Tepha Inc | 2 | $171 |
| Galderma Laboratories, L.p. | 5 | $108 |
| Revance Therapeutics, Inc. | 1 | $59 |
| Bard Peripheral Vascular, Inc. | 1 | $29 |
| Smith+Nephew | 1 | $23 |
| Convatec Inc. | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,970 in reported general payments places this provider in the 75th percentile of 70 plastic surgery providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 25 | $225 |
| ValacyclovirValacyclovir Hcl | 15 | $146 |
| Ondansetron OdtOndansetron | 15 | $67 |
| Oxycodone Hcl | 15 | $52 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Denver
- Damien BatesDenver$57K
- Philippe CapraroDenver$43K
- Karen LoDenver$9K
- John SquiresDenver$5K
- Christina LeeDenver$4K
- Linda HuangDenver$2K
- Edward MelkunDenver$1K
- Gary SniderDenver$701
- Jeffrey WheelerDenver$422
- Mark KiehnDenver$281
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.